Electromagnetic interference: Pacemakers, cardiac resynchronization therapy devices, implantable cardioverter–defibrillator

被引:2
|
作者
Nowak B. [1 ]
Przibille O. [1 ]
Napp A. [2 ]
机构
[1] Cardioangiologisches Centrum Bethanien, Im Prüfling 23, Frankfurt a.M.
[2] Medizinische Klinik I, – Kardiologie, Angiologie und Internistische Intensivmedizin, Uniklinik RWTH Aachen, Pauwelsstraße 30, Aachen
关键词
Cardiac arrhythmias; Cardiac implantable electronic devices; Cardiac pacemaker; Electromagnetic fields; Electromagnetic interference;
D O I
10.1007/s00399-022-00875-7
中图分类号
学科分类号
摘要
Patients with cardiac pacemakers, implantable cardioverter–defibrillators (ICDs), and cardiac resynchronization therapy devices (CRT) are exposed to different types of electromagnetic interference (EMI) at home and at work. Due to the constantly increasing role of electrically active appliances in daily use and the introduction of new therapy concepts such as the leadless cardiac pacemaker and the subcutaneous defibrillator, this topic is of great relevance. The further development of the implanted devices and the almost complete use of bipolar leads has reduced the overall risk of EMI. This review article provides information about the current status of possible interference in the private environment and how to avoid it. In addition, information is provided on how to deal with occupational sources of interference. © 2022, The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
引用
收藏
页码:297 / 304
页数:7
相关论文
共 50 条
  • [21] One Indication for an Extravascular Cardiac Resynchronization Therapy Defibrillator: Lessons from a Combination Therapy Case with Epicardial Cardiac Resynchronization Therapy and a Subcutaneous Implantable Cardioverter Defibrillator
    Ishii, Natsuko
    Nakajima, Kenzaburo
    Kakuta, Takashi
    Noda, Takashi
    Fujita, Tomoyuki
    Kusano, Kengo
    INTERNAL MEDICINE, 2021, 60 (12) : 1877 - 1880
  • [22] Implantable cardioverter-defibrillator and cardiac resynchronization therapy in patients with left ventricular noncompaction
    Kobza, Richard
    Steffel, Jan
    Erne, Paul
    Schoenenberger, Andreas W.
    Huerlimann, David
    Luescher, Thomas F.
    Jenni, Rolf
    Duru, Firat
    HEART RHYTHM, 2010, 7 (11) : 1545 - 1549
  • [23] Depression and anxiety in patients receiving an implantable cardioverter defibrillator with or without cardiac resynchronization therapy
    Sofia Plakoutsi
    Elizabeth Florou
    Dimitrios Sfairopoulos
    Petros Skapinakis
    Panagiotis Korantzopoulos
    Journal of Geriatric Cardiology, 2025, 22 (02) : 255 - 264
  • [24] Depression and anxiety in patients receiving an implantable cardioverter defibrillator with or without cardiac resynchronization therapy
    Plakoutsi, Sofia
    Florou, Elizabeth
    Sfairopoulos, Dimitrios
    Skapinakis, Petros
    Korantzopoulos, Panagiotis
    JOURNAL OF GERIATRIC CARDIOLOGY, 2025, 22 (02) : 255 - 264
  • [25] National Trends in the Use of Cardiac Resynchronization Therapy With or Without Implantable Cardioverter-Defibrillator
    Lindvall, Charlotta
    Chatterjee, Neal A.
    Chang, Yuchiao
    Chernack, Betty
    Jackson, Vicki A.
    Singh, Jagmeet P.
    Metlay, Joshua P.
    CIRCULATION, 2016, 133 (03) : 273 - 281
  • [26] Implantable Cardioverter Defibrillator in Cardiac Resynchronization Therapy Recipients With Advanced Chronic Kidney Disease
    Goldenberg, Ido
    Kutyifa, Valentina
    Zareba, Wojciech
    Huang, David T.
    Rosero, Spencer Z.
    Younis, Arwa
    Schuger, Claudio D.
    McNitt, Scott
    Polonsky, Bronislava
    Steinberg, John
    CIRCULATION, 2023, 148
  • [27] Economic Implications and Cost-effectiveness of Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy
    Bernard, Michael L.
    Gold, Michael R.
    HEART FAILURE CLINICS, 2011, 7 (02) : 241 - +
  • [28] IMPACT OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR FOR PRIMARY PREVENTION IN PATIENTS UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY
    Cabrera-Bueno, F.
    Molina-Mora, M. J.
    Pena-Hernandez, J.
    Leruite, I.
    Alzueta, J.
    Barrera-Cordero, A.
    De Teresa, E.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2009, 20 : S92 - S93
  • [29] FDA perspective on assessing the clinical benefit of cardiac resynchronization and implantable cardioverter-defibrillator devices
    Selzman, Kimberly A.
    JOURNAL OF ELECTROCARDIOLOGY, 2018, 51 (06) : S22 - S24
  • [30] IMPLANTABLE CARDIOVERTER DEFIBRILLATOR - POSSIBLE HAZARDS OF ELECTROMAGNETIC-INTERFERENCE
    SCHMITT, C
    BRACHMANN, J
    WALDECKER, B
    NAVARRETE, L
    BEYER, T
    PFEIFER, A
    KUBLER, W
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1991, 14 (06): : 982 - 984